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ABSTRACT. We examined the structure of the rat kinin B
2
 receptor gene 
(KB
2
r) and encoding messenger RNA (mRNA) processing. Differently from 
the closely related mouse and rabbit genes that have three exons and two 
introns, the rat gene purportedly consists of four exons and three introns. There 
are two purported gene products; one of them contains an upstream ~180-bp 
open reading frame region (“exon-X”) potentially expressed as a result of 
alternative processing. To examine the processing of rat KB
2
r mRNA, cDNA 
amplicons were generated using primer pairs directed towards 5’ or 3’ exon 
or intron flanking regions. Analyses of intron/exon primary cDNA amplicons 
showed that introns 1 to 3 are removed sequentially and that “exon-X” 
removal follows that of intron-3. No evidence was found for “exon-X” 
expression in polyadenylated (mature) mRNA of adult Wistar, Wistar 
Kyoto, spontaneously hypertensive or Sprague-Dawley rat tissues. Nor was 
“exon-X” detected in tissues subject to inflammatory stimulus expressing 
B
1
 kinin receptor mRNA or in 1- to 21-day-old rat embryos or fetuses. The 
lack of evidence for the expression of “exon-X” in mature mRNA indicates 
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that the structure of the rat gene is similar to that of the mouse, rabbit and 
human genes, all consisting of three exons and two introns. The “exon-X” 
fragment may result from interstitial gene duplication, be a fragment of the 
ancestral gene, or most likely heterologous transposon insertion of an exon-
like fragment into intron-2 of the KB
2
r gene. 
Key words: Alternative processing; Rat embryos; Kinin B
2
 receptor gene
INTRODUCTION
Bradykinin, a potent neuropeptide and a vasoactive peptide, has a wide spectrum of 
biological activities (Couture and Lindsey, 2000; Leeb-Lundberg et al., 2005). Under physi-
ological conditions, kinin activity is mediated by the interaction of the B
2
 kinin receptors (Leeb-
Lundberg et al., 2005). These are present in organ and arterial smooth muscle cells and in rat 
and human brain nuclei, such as the paratrigeminal nucleus and the nucleus of the solitary tract 
(Lindsey et al., 1997; de Souza Buck et al., 2002). Stimulation of arterial B
2
 kinin receptors 
causes resistance vessel vasodilatation and hypotension (Sharma, 2006). On the other hand, 
stimulation of central kinin receptors leads to blood pressure increases (Lindsey et al., 1997), 
mediated by central sympathetic mechanisms (Caous et al., 2004). Thus, among other impor-
tant functions, such as blood pressure regulation, kinins are characterized as mediators of pain 
and inflammatory responses, both in the central and in the peripheral nervous systems (Leeb-
Lundberg et al., 2005); they are also important mediators in the cascade of the febrile response 
(Pessini et al., 2006). Additionally, bradykinin apparently plays a role in the rat reproductive tis-
sues via the kinin B
2
 receptor (Holland et al., 2001). As vascular agents, they promote vascular 
permeability and vasodilatation (Leeb-Lundberg et al., 2005), which are important mechanisms 
related to the anti-hypertensive action of kinase II inhibitors (Lindsey et al., 1987). 
Two receptor types, both of the protein G receptor family, are known to mediate kinin 
effects in different tissues throughout the body (Leeb-Lundberg et al., 2005). The B
1
 receptor, 
normally not present in healthy tissues, has its expression promoted by inflammatory responses 
caused by injury, infection, or endogenous and exogenous pyrogens (Lungu et al., 2007). The 
transcription nuclear factor κB is involved in inducible expression of the human and rat B
1
 re-
ceptor gene (Ni et al., 1998; Medeiros et al., 2004). On the other hand, the B
2 
kinin receptor is 
constitutively expressed in most body tissues and is commonly involved in most of the biologi-
cal activity of kinins in healthy tissues (Leeb-Lundberg et al., 2005). 
In the rat, the coding sequence of B
2
 kinin receptors, deduced from cDNA (McEachern et 
al., 1991), and the cloning and sequencing of the gene (Pesquero et al., 1994; Wang et al., 1994) 
accompanied molecular characterization of the human (Eggerickx et al., 1992; Powell et al., 1993; 
Park et al., 1994; Ma et al., 1994a; Kammerer et al., 1995), murine (McIntyre et al., 1993; Ma 
et al., 1994b), guinea pig (Farmer et al., 1998), rabbit (Bachvarov et al., 1995), dog (Hess et al., 
2001), chicken (Schroeder et al., 1997), frog (Suzuki et al., 2007), and zebrafish (Bromée et al., 
2005) B
2
 receptor gene. The B
1
 receptor gene has also been cloned and sequenced from humans 
(Bachvarov et al., 1996), rabbits (MacNeil et al., 1995), mice (McIntyre et al., 1993) and rats 
(Ni et al., 1998; Jones et al., 1999). Genomic Southern blot analysis of human, rabbit and rat 
genomes revealed that a single-copy gene encodes the kinin B
2
 receptor (Kammerer et al., 1995; 
Bachvarov et al., 1995). This also holds true for the human B
1
 receptor (Bachvarov et al., 1996). 
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Several reports indicate that the gene of these two receptors contains three exons separated by two 
introns and an intronless coding region located on the third exon (McIntyre et al., 1993; Ma et al., 
1994a,b; Wang et al., 1994; Bachvarov et al., 1995). However, Pesquero et al. (1994), based on the 
findings of others (McEachern et al., 1991), included an “extra” exon in the gene, predicting a four 
exon-three intron gene structure for the rat (Ratus norvegicus) kinin B
2
 receptor gene. Alternative 
splicing of B
2
 receptor mRNA would result in rat “exon-3”, herein named “exon-X”. This exon, 
not predicted for mice or for the human kinin B
2
 receptor gene, was suggested based on evidence 
from amplification of reverse-transcriptase products from total RNA (Pesquero et al., 1994). Re-
sults obtained with domain-specific anti-peptide antibodies, amino acid sequence analysis and 
in vitro transcription and translation suggested a first translation initiation codon in the human 
and rat “exon-X” (AbdAlla et al., 1996) rather than in exon-4, as previously thought. This would 
imply a four-exon structure for the rat and human kinin B
2
 receptor gene. Translation of gene 
products initiating either in rat or human exon-3 or exon-4 would putatively lead to expression 
of B
2
 receptor subtypes. However, translation products containing the extended N-terminus have 
never been reported in rats or humans (Couture and Lindsey, 2000).
Alternative processing has been suggested for a number of receptor proteins, includ-
ing rat kinin B
1
 (Ni et al., 1998), the NK1 tachykinin (substance P) receptor (Page, 2006), the 
endothelin B receptor (Suzuki et al., 2004) and the glutamate-receptor-coupled ion channel 
(Kumar et al., 2009). However, experimental evidence shows that the single type of mature, 
polyadenylated mRNA does not contain the proposed “exon-X”. Furthermore, given that the 
rat B
2
 gene is highly related to the mouse and guinea pig genes, a different gene structure and 
alternative processing of the rat B
2
 receptor mRNA is unlikely.
For a better understanding of the processing of rat kinin B
2
 receptor gene products and 
to gain insight concerning gene structure, we analyzed mature and immature RNA transcripts 
in adult hypertensive and normotensive rat strains, rat embryos and fetuses, as well as in ani-
mals expressing the B
1
 kinin receptor induced by pyrogen treatment. The 211 bp of the pur-
ported “exon-X” kinin B
2
 gene and predicted protein sequences were respectively compared 
to available data base sequences for a clearer understanding of the structure of this particular 
gene as to further our knowledge on gene structure and evolution.
MATERIAL AND METHODS
Tissue specimens
Tissues were collected from five adult (three months old) Wistar, Wistar Kyoto, spon-
taneously hypertensive rats (SHR; Okamoto et al., 1964), and Sprague-Dawley male and 
female rats. Under CO
2
 anesthesia, animals were quickly dissected for removing the aorta, 
mesenteric arteries, liver, uterus, lungs, ovaries, hypothalamus, lower brainstem, solitary tract, 
and paratrigeminal nuclei. Approximately 50 mg of each tissue sample was rapidly frozen in 
liquid nitrogen and then stored in phenol solution (Trizol, Invitrogen Corporation, Carlsbad, 
CA, USA) at -80°C for not over 24 h before processing.
Embryo collection
Five female Wistar rats per group were treated with 150 IU/kg pregnant mare serum 
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gonadotropin (Sigma Chemical Company, St. Louis, MO, USA) and after 46 h with 75 IU/
kg human chorionic gonadotropin (Sigma Chemical Company) to provoke super ovulation. 
Animals were mated and 24 h later vaginal smears were collected for pregnancy verifica-
tion. From days 1 to 5, 50 embryos were collected from oviducts of 10 rats with 80 μL 
hyaluronidase (Sigma Chemical Company) to detach embryo cells from granulosa cells; the 
embryos were washed with M2 and stored in M16 medium (Sigma Chemical Company) and 
stored in phenol solution at -80°C. Six- to 21-day fetuses were directly collected from the 
rat uterus, chopped into small pieces, homogenized in a phenol solution, rapidly frozen in 
liquid nitrogen and stored at -80°C. 
LPS treatment
Sixteen animals were injected intraperitoneally with the vehicle alone or 50 μg/kg Esche-
richia coli bacterial endotoxin lipopolysaccharide (LPS, Sigma Chemical Company) 4 h before sac-
rifice. Body temperature was monitored every 15 min to determine if there was a febrile response. 
RNA extraction
Embryos or 50 mg samples of tissues or fetus were homogenized in 1, 2 or 3 mL phe-
nol. Following addition of chloroform, total RNA was precipitated from the aqueous phase 
with isopropanol and washed with 75% ethanol.   
Reverse transcriptase and amplification reactions
Five-microliter aliquots of total RNA, suspended in RNAse-free water, were submit-
ted to reverse transcriptase (Mulv, Invitrogen Corporation) and c-DNA amplification (Ther-
moScript RT-PCR system, Invitrogen Corporation) with oligo dT primers for mature mRNA 
or with random primers for primary mRNA. c-DNA amplification was carried out with se-
lective primers directed towards regions close to the intron/exon boundaries. Amplification 
products were revealed on 1.5% agarose gels (Gibco, New York, USA). Selected samples 
were reamplified and the reaction products examined on silver-stained 12.5% polyacrylamide 
gels (PhastSystem, Pharmacia Biotech, Uppsala, Sweden) and stained with ethidium bromide 
(United Biochemical Corp., Cleveland, OH, USA). Uterine samples were cycle-sequenced 
using an Alf automatic sequencer (Pharmacia Biotech). 
Statistical analysis
All data are reported as means ± SEM and were analyzed by ANOVA followed by the 
Student t-test for unpaired analysis. Results with P < 0.001 were considered to be significant.
RESULTS
Processing of the kinin B
2
 receptor gene
In order to investigate the sequence of intron removal, primary mRNA cDNA was 
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Protein                      Location/nucleotide                  Nucleotide sequence                              Expected product sizes (kb/bp)
    Primary mRNA Ripe mRNA
Kinin B
2
 receptor
   fKB
2
-E1a Ex1-Ex3  74 to 95 5’GAC TCC CTA CAA CAC AGA ACC G 3’ ~3.5, 1.7, 0.9, 0.7 702
   rKB
2
-E3a   986 to 966   5’ CCG TGA CGT TGT GCC CCT CTT 3’
   fKB
2
-E2 Ex2-Ex3  160 to 177 5’AAG CGA CCC GTG CTC CTG 3’ ~2.9, 1.2, 0.38, 0.17 169
   rKB
2
-E3   539 to 518 5’ CCT GGA TGG CAT TGA GCC AGC T 3’  
   fKB
2
-EX  ExX-Ex3 294 to 313 5’CGC TGT GCC TCC TCC CGT GC  3’ ~1.1, 0.25 -
   rKB
2
-E3   539 to 518 5’ CCT GGA TGG CAT TGA GCC AGC T 3’  
   fKB
2
-In2 In2-Ex3   -120 to -140 5’ GCA TCT TCA TAA TCA TGC TT 3’ ~1.1 -
   rKB
2
-EX   539 to 518  5’ CCT GGA TGG CAT TGA GCC AGC 3’  
   fKB
2
-In1  In1-ExX  -250 to -271 5’ GAG CAT CCA GTG CTC ATA ATG 3’ ~2 -
   rKB
2
-E3b   353 to 332 5’ TTG TGT CCA TGC AGC AGA GCA C 3’  
Kinin B
1
 receptor
   fKB
1
-E1 Ex1-Ex2  143 to 162 5’ CTG TGG ATG GCG TCC GAG GT 3’ - ~806 bp
   rKB
1
-E3   939 to 923  5’ GCT ACC AGT GTG AGG AT 3’
β-actin
   fBAc-E1 Ex2-Ex4    92 to 108 5’ ATA TCG CTG CGC TCG TC 3’ - 597 bp
   rBAc-E2   688 to 670 5’ TGG TGG TGA AGC TGT AGC C 3’
Table 1. Location of primer pairs, nucleotide sequences and amplification product sizes expected for cDNA of 
primary or ripe mRNA from Wistar rat kinin B
2
, kinin B
1
 receptor and ß-actin proteins.
amplified with primers directed to 3’ boundaries of introns 1, 2, or 3 and to the 3’ regions 
of the downstream exons. Table 1 shows the primer location on the kinin B
1
 and B
2
 recep-
tors as well as on the reference β-actin protein-encoding genes; it also shows the expected 
size of the respective amplification products.
Contrary to exon/exon primer pairs that generated multiple fragments, each intron/exon 
primer pair produced only one amplification product. Thus, intron-1, -2 and -3/exon-3 primer 
pairs generated 0.17-, 1.1- and 3-kb fragments, respectively, each containing all downstream in-
trons and exons of the gene (Figure 1A). This may be taken as unequivocal evidence that introns 
1, 2 and 3 are removed in sequential order. Similarly, the intron-2/exon-3 primer pair produced a 
1.2-kb fragment containing “exon-X”, intron-3 and the 5’ region of exon-3 (Figure 1A).
On the other hand, amplification of primary mRNA with primers directed towards 
5’ regions of exons and 3’ regions of downstream exons produced multiple fragments, cor-
responding to the different stages of mRNA processing. The exon-1/exon-3 primer pair pro-
duced four fragments: a 702-bp product containing exon-2 and the 3’ and 5’ areas of exons 1 
and 3; a 913-bp fragment containing exon-2 and exon-X; a 1.1-kb fragment containing exon-2, 
exon-X and intron-3, and a 3-kb product containing, in addition to the latter, 1.8 kb of intron-2. 
The ~26-kb fragment containing the ~23-kb sequence of intron-1, if amplified to any extent, 
would be unresolvable on high-density gels. 
The exon-2/exon-3 primer pair produced four products, with sizes of 0.17, 0.38, 1.3, 
and 3.1 kb, all homologous to the fragments described above. The exon-X/exon-3 primer pair 
generated two products sized 0.23 and ~1.1 kb, one of which contained the 0.8-kb sequence of 
intron-3, making “exon-X” the last fragment to be removed (Table 1, Figure 1). 
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Figure 1. The processing of the rat B
2
 kinin receptor protein. A. Reverse transcriptase amplifications of primary 
and mature mRNA representative of Wistar, Wistar Kyoto, Sprague-Dawley, and spontaneously hypertensive rat 
tissues. To the left, agarose gels showing exon-1/exon-3, exon-2/exon-3 and “exon-X”/exon-3 primary mRNA 
amplicons. The top right gel shows primary mRNA amplicons of intron-1/exon-2 and intron-2/ “exon-X” primer 
pairs. At the bottom right, the mature mRNA amplification products of exon/exon primer pairs. B. Representation 
of the processing of the kinin B
2 
gene, deduced from the analyses of exon/exon and intron/exon amplification 
products shown in A. Note the sequential removal of introns 1, 2, and 3, followed by that of “exon-X”, representing 
a three-exon gene structure in the form of mature mRNA genomic transcripts. M = molecular weight marker; L 
= liver; H = hypothalamus; U = uterus; Cap = 5´capping of primary mRNA; Poly-A tail = polyadenylation of 3’ 
mature mRNA. 
Exon composition of kinin B
2
 receptor-encoding mature mRNA
The amplification of reverse transcribed cDNA from polyadenylated mRNA (RT/
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PCR) generated only one gene product, independent of the primer pair, with the exception of 
the primer pairs with one constituent directed towards exon-X. Thus, the exon-1/exon-3 pair 
produced a 702-kb fragment and the exon-2/exon-3 primer pair produced a 170-kb product. 
Amplification of mature, polyadenylated mRNA of brain and visceral tissues, such 
as paratrigeminal nuclei, nuclei of the solitary tract, uterus, ovaries, stomach, liver, kidneys, 
and lungs of Sprague-Dawley, Wistar and Wistar Kyoto rat strains, with exon-1/exon-3 primer 
pairs only produced the 702-bp fragment containing 5’ exon-1, exon-2 and 3’ exon-3. The 
same held true for the amplification of mature mRNA from SHR (data not shown). Ten-micro-
liter aliquots uterus amplification reactions were re-amplified and resolved on silver-stained 
12.5% polyacrylamide gels. In spite of the high sensitivity of the procedures, no trace of the 
211-bp exon was detected. The “exon-X”/exon-3 pair failed to amplify the B
2
 kinin receptor 
mature mRNA in any of the tissues (Figure 1).
Cycle sequencing of primary and mature mRNA cDNA transcripts only identified the 
“exon-X” 211-bp nucleotide sequence in the primary mRNA transcripts (Figure 2). 
Figure 2. Genomic sequence showing contiguous exon-2 3’ and exon-3 5’ regions (displayed in grey boxes) obtained 
by cycle-sequencing ripe kinin B
2
 receptor-encoding mRNA. In the white box, the genomic sequence of the 211-bp 
“exon-X” is interposed between exons 2 and 3. The latter was obtained by sequencing the 913-bp primary mRNA 
amplicon produced by the same exon-2/exon-3 primer pair used for immature mRNA amplification.
Exon composition in pyrogen-treated rats
Mature mRNA was also examined in rats treated with an exogenous pyrogen, a bacte-
rial LPS. Fifty micrograms LPS administered directly into the rat peritoneum produced fever 
and expression of B
1
 kinin receptor mRNA, without altering the expression of the kinin B
2
 re-
ceptor or the β-actin protein mRNA (Figure 3A). The exon-1/exon-3 primer pair yielded only 
one 702-bp product, both in naive and LPS-treated animals. Figure 3B shows the expression 
levels of B
1
 and B
2
 mature receptor mRNA in the different tissues of the Wistar rat.
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Figure 3. Expression of B
1
 kinin receptor encoding mRNA in tissues of pyrogen (bacterial lipopolysaccharide, 
LPS)-treated (50 μg/kg, ip) rats. A. Amplification products of B
1 
and B
2
 kinin receptor mRNA and of the β-actin 
protein in ripe mRNA. B. Relative expression of B
1 
and B
2
 mRNA in central nervous system structures, such as the 
medulla (M); hypothalamus (H); paratrigeminal nucleus (Pa5); nucleus of the solitary tract (NTS); the mesenteric 
artery (Mes); aorta (A); kidney (K); stomach (S); lung (L); uterus (U); ovary (O).
B
2
 kinin receptor expression during ontogenetic development
Primary and mature mRNA was obtained from rat embryonic and fetal tissues at 1 to 
21 gestational days. cDNA amplification showed that the 0.6-kb product of the β-actin protein 
and the 702-bp product of the B
2
 kinin receptor were expressed in embryonic cells from day 
1 through 21, both from primary and mature mRNA. In primary RNA, the 913-bp product 
containing “exon-X” was apparent from day 5 onwards. The 702-bp fragment (not containing 
“exon-X”) was the only amplification product of the exon-1/exon-3 primer pair from mature 
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mRNA cDNA (Figure 4A). Reamplification of 10-mL samples of the PCR amplification reac-
tions, resolved on silver-stained polyacrylamide gels, failed to identify the 913-bp product 
containing the 211-bp sequence. Expression of the 702-bp fragment increased relative to that 
of the reference β-actin protein from gestational days 8 to 14 (Figure 4B). 
Figure 4. Kinin B
2
 receptor encoding primary and mature mRNA expressiom in rat embryos and fetuses. A. Exon-
1-3 amplicons mature kinin B
2
 receptor mRNA showing the single 702-bp bands at different days of ontogenetic 
development (center). To the left, amplification of mature mRNA β-actin reference protein and to the right exon-1/
exon-3 B
2
 receptor primary mRNA amplicons showing both the 702- and the 211-bp bands, the latter containing 
“exon-X”. M = molecular weight marker. B. Expression of kinin B
2 
receptor mature mRNA relative to that of 
β-actin mature mRNA at the different embryogenic phases over the 21-day gestational period.  
Data base matching of gene products and predicted proteins
The rat “exon-X” 211-bp sequence does not share any homology with the re-
cently described kinin B
2
 receptor gene sequence predicted from the rat mature mRNA 
(Genbank, Rattus norvegicus accession number NM_173100.1), horse (Equus caballus, 
XM_001489272.1), domestic cow (Bos taurus, XM_583508.3), mouse (Mus musculus, 
NM_009747.2), rabbit (Oryctolagus cuniculus, U33334 ), guinea pig (Cavia porcelus, 
AJ003243.1), dog (Canis lupus familiaris, NM_001003095.1), human (Homo sapiens, 
NM_000623), chicken (Gallus gallus, NM_001031553.1), and frog (Xenopus tropicalis, 
BC155000.1). “Exon-X” displayed full homology to the kinin B
2
 receptor genes de-
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scribed by McEachern et al. (1991) and Pesquero et al. (1994) (a P25023). However, 
when compared to the entire rat or mouse kinin B
2
 receptor gene sequences, significant 
homology of exon-X was found with intron regions (Table 2). Within the 211-bp se-
quence from Srague-Dawley or Wistar rat, 210 bp showed 96% homology to the 46554-
46770 region of the Rattus norvegicus genome (NW_047762.2) and 172 bp showed 76% 
homology to the Mus musculus genome (31444-31669, NT_166318.1). In both cases, the 
alignments occurred in intron regions between exons 2 and 3 of the respective kinin B
2
 
receptor genes. On the other hand, 18 bases of the rat “exon-X” 211-bp sequence showed 
90% homology alignment to the exon-3, 3’ untranslated region (UTR, 47101-47120), of 
the Homo sapiens kinin B
2
 receptor gene (NT_026437.12).  
Mouse exon-1 displayed 84% homology to 96 bases of rat exon-1, while the hu-
man gene showed 100% homology to 12 bases of the 111-bp rat exon-1. Eighty-two bases 
of the 104-bp rat exon-2 showed 83% homology to the mouse gene, while 30 bases of the 
same exon displayed 81% homology with the human gene exon-2. We also found that 1.35 
kb of the rat 3’ UTR (exon-3) had 82% homology to the mouse 3’ UTR, while 39 bases 
of the latter displayed 82% homology to human kinin B
2
 receptor gene 3’ UTR. However, 
a 662-bp segment of the rat 3’UTR aligned to the mouse gene region, immediately fol-
lowing the 3’ open-reading frame (ORF), while a contiguous 685 segment aligned 988 bp 
downstream (Table 2). 
The rat exon-3 ORF showed high compatibility to the mouse (92%) and human 
(83%) kinin B
2
 receptor encoding sequences. As in the rat, the mouse and human ORFs 
have a continuous 1.1-kb sequence, all in 5’exon-3 (Figure 5B). However, when the rat 
ORF was aligned to mouse or human kinin B
2 
receptor gene sequences predicted from 
mRNA (GenBank NM_009747.2 and NM_000623, respectively), ~70 bp of the 3’ region 
showed homology to mouse and human exon-2, revealing an error in the deduced gene 
structures.
Sprague-Dawley rat Rattus norvegicus (39.7 kb)  Mus musculus (37.4 kb) Homo sapiens (49.4 kb)
 chromosome 6 chromosome 12 chromosome 14
Genbank: P25023 Genbank: NW 047762.2 Genbank: NT_166318.1 Genbank: NT_026437.12
Exon-1 (111 bp) Not available 96/114 (84%): 3703-3815 12/12  (100%): 1583-1594
Exon-2 (104 bp) 104/104 (100%): 44784-44887 82/98 (83%): 28764-28861 30/37 (81%): 37287-37321
Exon-X (211 bp) 210/217 (96%): 46554-46770 172/226 (76%): 31444-31669 18/20 (90%): 47101-47120
Exon-X (Wistar rat) (211 bp) 210/217 (96%): 46554-46770 Idem Idem
Exon-3 (3711 bp) 3711-3720 (99%): 47531-51242 1683/1896 (88%): 32140-34000 939/1146 (81%): 40583-41723
  685/854 (80%): 34988-35801
ORF Exon-3 (1101 bp) 1101/1101 (100%): 47538-48639 1013/1101 (92%): 32147-33247 888/1067 (83%): 40583-41649
3’UTR Exon-3 (2603 bp) 2601/2604 (99%): 48639-51242 662/786 (84%): 33248-34000 39/47 (82%): 43763-43809
  685/854 (80%): 34988-35801
aReference gene (Rattus norvegicus) segment to align with species genome-derived kinin B2 receptor genes. The 
numbers in parentheses represent homology of the respective alignments. bRegions of species kinin B2 receptor 
genes to which the reference gene aligned to. ORF = open-reading frame; UTR = untranslated region.
Table 2. Sprague-Dawley rat kinin B
2
 receptor gene alignment with the rat, mouse and human genes.
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Figure 5. A. Gene structure of the kinin B
2
 receptor gene showing three exons, the introns and the putative 
“exon-X”, which apparently is not expressed in mature mRNA of the rat or other species. The first AUG translation 
initiation codon in exon-3 is depicted in the mature mRNA (dark vertical bar) alongside the 1100-bp open reading 
frame (ORF), which is followed by a UGA stop codon. The 3’ and 5’ untranslated regions (UTR) in exons 1 and 2 
or exon-3, as well as the non-functional upstream AUG initiation codons (uAUGs, light vertical bars) in exons 1 
and 2 are depicted in their approximate positions. B. Alignment of the Sprague-Dawley rat kinin B
2
 receptor exons 
with the rat (Rattus norvegicus) chromosome 6, the mouse (Mus musculus) chromosome 12 and human (Homo 
sapiens) chromosome 14 genes.
The predicted N-terminal ~27 residue related to the 211-bp rat kinin B
2
 receptor 
gene “exon-X” did not match published amino acid sequences (Genbank, accession number 
P25023). Curiously, the predicted alternative N-terminus of human, rat and mouse proteins 
(AbdAlla et al., 1996) displayed negligible homology with each other. Figure 5A shows the rat 
kinin B
2
 receptor gene structure and Figure 5B shows the respective encoding mature mRNA 
and exon alignments to the mouse and human genome.  
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DISCUSSION
We describe new details of the processing of the B
2
 kinin receptor-encoding mRNA; 
the introns are sequentially removed, since amplification of cDNA from primary mRNA with 
intron/exon primer pairs produced only one product containing all downstream introns and 
exons. During processing, “exon-X” is the last fragment to be removed. This occurs after 
removal of intron-3, suggesting that “exon-X” may have been incorporated to intron-2 of mu-
rines or phylogenetic ancestrals. Notwithstanding the evolutionary significance of this frag-
ment, our finding that the 211 bp is not present in mature mRNA led us to conclude that the rat 
B
2
 receptor gene structure is similar to that of mice, humans, and probably other mammalian 
species (Figure 5). Moreover, this interpretation of the rat gene coincides with a recently 
published consensus sequence of the N-terminus rat kinin B
2 
receptor gene (Genbank acces-
sion No. NM_173100). In the latter sequence, deduced from the murine and human kinin B
2
 
receptor published by McIntyre et al. (1993), in which the 211-bp sequence of “exon-X” is 
not portrayed. This updated N-terminal rat kinin B
2 
receptor sequence is presently used as a 
reference for the rat gene (Martins et al., 2008; Sivritas et al., 2008; Hansen et al., 2009; Tang 
et al., 2009). We also now have a better understanding of the mouse and human kinin B
2
 recep-
tor genes. As in the rat, the mouse and human ORFs consist of a continuous 1.1-kb sequence, 
all contained in 5’exon-3 (Figure 5). In contrast, earlier models of the mouse and human 
gene structures predicted from mRNA (Ma et al., 1994b; Hess et al., 1992) showed 0.7 kb of 
3’ORF regions of mouse and human exon, 2 with the reminder of the ORF region in exon-3. 
Investigation of the murine and human genomes permitted identification of the mistake in 
gene structure prediction; consequently, the concept of the kinin B
2
 receptor or gene-encoding 
region being in one intronless exon is also sustained for the mouse and human genes.
When we examine rat kinin B
2 
receptor gene product processing,
 
it is not yet clear 
whether the observed fragment removal pattern is common to the processing of other receptor-
protein gene products of the same family. The fact that the “exon-X” nucleotide sequence was 
not found in polyadenylated mature mRNA in a wide range of tissues pertaining from various 
rat strains, both in unstimulated tissues or during an acute inflammatory process, which pro-
motes expression of B
1
 kinin receptor mRNA, practically rules out the possibility of alternative 
processing of the B
2
 receptor gene that would lead to expression of an “exon-X”-containing 
mature gene product in adult animals. Furthermore, the lack of evidence for sustained expres-
sion of kinin B
2
 receptor encoding gene products during early and late embryonic develop-
ment is further evidence that the “exon-X”-containing gene product is not a constitutively or 
inductively expressed gene sequence in the mature or developing rat.
During the initial cloning of the rat kinin B
2
 receptor gene by McEachern et al. (1991), 
the “exon-X” gene was included as part of the gene-encoding sequence. This lead to a hypoth-
esis of alternative processing of the B
2 
receptor protein gene. According to this hypothesis, 
alternative gene splicing would produce two mature mRNAs, one of them containing the 
211-bp sequence of “exon-X”, the earlier initially dubbed “exon-3” (Pesquero et al., 1994). 
The latter configuration suggested a four-exon, three-intron gene structure for the rat gene. 
Others (AbdAlla et al., 1996), based on in vitro studies, reported that the “exon-X” transcripts, 
containing an AUG initiation codon anteceding an ORF in the purported “exon-X”, would 
add about 27 amino acids to the N-terminal end of the human and rat kinin receptor proteins. 
The reasons for “exon-X” to be mistakenly identified as a constituent of the mature B
2
 kinin 
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receptor mRNA (Pesquero et al., 1994) are hinged on two non-converging aspects apart from 
the misleading published information (McEachern et al., 1991). First, the methodology used 
to isolate the poly-adenylated mRNA (poly-T columns) was not sufficiently stringent and thus 
permitted substantial amplification of primary mRNA transcripts containing “exon-X” genetic 
material. Second, the late removal of “exon-X”, after that of intron-3, generating an apparent 
four-exon amplification product (albeit unsuspectingly amplified from primary mRNA), re-
sulting in a false perception of an anticipated four-exon, three-intron gene structure. Here, we 
amplified mature mRNA from reverse transcripts using poly-T primers as transcription initia-
tors. The stringency of this approach is attested by the fact that fragments containing intron 
sequences were never amplified from polyadenylated mRNA preparations.
However, these findings clearly demonstrate a functional three-exon gene structure 
for the rat kinin B
2
 receptor gene, notwithstanding the purported in vitro expression of trans-
lated “exon-X” ORF N-terminal residues. In fact, the transcribed sequence that putatively 
encodes the rat “exon-X” ORF is not identifiable in the mammalian, avian, amphibian nor 
teleost fish genes encoding the kinin B
2
 receptor proteins. The fact that mature mRNA contain-
ing the “exon-X” sequence was not detected in embryonic rat mRNA may not be relevant to 
this hypothesis, since it could be expressed in minute amounts, in specific tissues and during 
a very short time period, possibly hours or less, as may be the case for the ETB endothelin 
receptor gene during ontogenetic development of the gut (Suzuki et al., 2004). Neither does 
this mean that the potentially extended kinin B
2
 receptor protein would necessarily be devoid 
of function if were expressed during early development. The lack of expression of the ETB 
receptor in the gut during a short period of organogenesis leads to a condition analogous to that 
of muscularis inflammation and the loss of Cajal interstitial cells, leading to intestinal obstruc-
tion and premature death of sub-adult endothelin-ETB receptor cells (Suzuki et al., 2004). The 
expression of the kinin B
2
 receptor encoding mRNA sharply increases in proportion to that of 
β-actin protein during early organogenesis and levels off during fetal growth, demonstrating 
the significance of this kinin B
2 
receptor for the multiple physiological functions played by 
kinins in the mature organism.   
“Exon-X”-containing mature mRNA was not found in a wide range of tissues of adult 
Wistar, Sprague-Dawley and SHR animals, including brain structures known to express high 
densities of kinin receptors, such as the nucleus of the solitary tract, the paratrigeminal nucle-
us. Neither was the “exon-X”-containing mature mRNA found in the hypothalamus, which ex-
presses components of the kinin-kallikrein system (Couture and Lindsey, 2000). The visceral 
tissues that were examined included those of arteries, lungs, kidneys, liver, stomach, ovaries, 
and uterus; the latter tissue was used for molecular cloning of the B
2
 kinin receptor gene. 
Thus, the structure of the rat gene may be considered akin to that of the mouse and 
human kinin B
2
 receptor genes; all include a three-exon structure, as depicted in Figure 5. 
The latter displays the three-exon gene structure of the kinin B
2
 receptor gene, based on our 
interpretation here and the finding of a single mature mRNA product. The lack of success in 
finding homology of the predicted ~30 residue N-terminal of the human or rat kinin recep-
tor (AbdAlla et al., 1996) with the predicted kinin proteins of the frog (Suzuki et al., 2007), 
zebra and puffer fish (Bromée et al., 2005, 2006), as well as avian and mammal proteins, sug-
gest that the “exon-X”-encoded protein N-terminus is not expressed in these animal classes. 
However, the 211-bp sequence of exon-X still has significant homology with the mouse intron 
region between exons 2 and 3. Comparing rat and mouse exons 1, 2 and “X” gives interspe-
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cies homology ratings of 84, 83 and 76%, respectively; it appears that the latter gene fragment 
is under lower conservational pressure (Kumar and Hedges, 1998; Blair Hedges and Kumar, 
2003) than exons 1 and 2. The same holds true when compared to the 1.3-kb sequence of the 
rat 2.6-kb 3’ UTR. Half of the 1.3-kb sequence aligned with position 33248-34000 and the 
other half with position 34988-35801 of the mouse kinin B
2 
receptor gene. The homology of 
these alignments was 84 and 80%, respectively, suggesting that the 3’ UTR of the gene are 
under greater selective pressure (Blair Hedges and Kumar, 2003) than exon-X. Curiously, 
18 bases of the 211-bp sequence showed 90% homology with the human 3’ UTR at position 
47101-47120. The significance, if any, of the latter sequence homology, which covers only 
8.5% of “exon-X”, is not clear.
Further investigation will be required to understand the evolutionary implications of 
“exon-X”. It is possible that this fragment is the result of an early interstitial gene duplication 
(Prowald et al., 2005), resulting in the 211-bp insertion, with subsequent loss of the duplicate 
sequence. “Exon-X” could also be an ancestral form of the gene. Considering that “exon-X” is 
removed late during processing after the downstream intron-3 and that it has an AUG initiation 
codon that in in vitro systems prevails over the in vivo functional exon-3 translation-initiation 
codon, it is possible that the current gene structure reflects earlier forms of this protein, prob-
ably expressed in phylogenic ancestrals of amphibians and teleosts. However, a more com-
pelling hypothesis for the origin of this 211-bp fragment is that it arose from a homologous, 
orthologous or heterologous transposon inserted before the 3’ flanking regions of kinin B
2 
receptor intron-2. This exon-like fragment, containing an AUG close to its 5’ extremity, would 
create an impression of a four-exon, three-intron gene structure. Transposable elements (Nek-
rutenco and Li, 2001) together with polyploidy duplication (Beçak and Kobashi, 2004) are one 
of the main mechanisms for promotion of diversity and genetic material gain in vertebrates. 
Approximately 90% of the transposons in a phylogenetically recent and rapidly evolving spe-
cies, such as Homo sapiens, were inserted into introns (Nekrutenco and Li, 2001) and were 
recruited into encoding regions as novel exons. 
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